In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia - Wikidata - wikimedia - TriplyDB

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

http://www.wikidata.org/entity/Q33601277

about

Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease A Potential Alternative against Neurodegenerative Diseases: Phytodrugs Brain imaging in Alzheimer disease Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Functional neuroimaging in Parkinson's disease Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Functional network disruption in the degenerative dementias.CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.Amyloid imaging of Lewy body-associated disorders Hyposmia and cognitive impairment in Gaucher disease patients and carriers Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions.An update on brain imaging in parkinsonian dementia Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent.Molecular imaging of Alzheimer disease pathology Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography Multimodality imaging characteristics of dementia with Lewy bodies.Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.Brain amyloid and cognition in Lewy body diseases.Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association Amyloid-β positron emission tomography imaging probes: a critical review.Disclosure of amyloid imaging results to research participants: has the time come?Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia.Cerebral amyloid PET imaging in Alzheimer's disease.Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.Functional imaging of cognitive impairment in Parkinson's disease.Imaging cognitive and behavioral symptoms in Parkinson's disease.

P2860

Q24632112-E880E66F-27B3-43A6-A084-202B639454B3 Q26744782-6BC2871A-9336-4C90-8282-22FE45128467 Q26765784-EB9EADE5-E756-4E7A-9244-6689479C3BB3 Q26996299-2AC2D1D9-156E-43BD-A590-FB646CD716F2 Q27009411-1B745EE7-1CA3-4CD7-B3EE-E533C5B8592B Q27013767-1D84B262-CC71-4AEA-83B4-F44BBCE439EB Q30422060-A4E9CEB2-8517-41A1-BEE8-B6A6962327B5 Q31097119-01B614DB-8B20-46BA-ACCC-F4E77D8A5FB4 Q33967680-5F33302A-15FC-4958-B3EC-924E32812481 Q34299993-540520CF-99BC-49C8-9D68-21D101DBE4C9 Q34300244-218F4E70-CE4A-4FFE-A6DB-9FCC1DA802AD Q34300690-7421348A-5108-4EE5-86C3-0CF05FDDC92A Q34318022-F680F45D-186D-4190-BC6F-217DB0837513 Q34327937-BF566CA8-3315-4DA6-8B6B-F52E5E14F562 Q34584062-DDAC5B1E-93D3-4F80-9537-51079C74834C Q34651135-C0198A0E-CDE2-496E-B923-958A21A31709 Q34714560-EF744737-56A5-4A70-A2A5-5044663C146E Q35551001-B5356E31-F910-4833-8C71-8C85F51CB457 Q35600979-3035DE57-1252-4C32-938C-08FCC8476C5F Q35612090-73EBADBC-1B20-4D9B-A9BF-824C861E2B2A Q35776066-64266BA3-DC66-40AF-ABBE-FAF8C44CC335 Q35777166-F198D525-F80A-457A-BC52-B81CF89E3DD3 Q35785744-21C34444-4F39-4F85-91B8-51265B5AAF27 Q35940191-1BD0DEFB-5F21-4257-80AF-CD4E79FF3908 Q36011353-BABA0D2C-FD3B-4BBE-A2ED-942D5B6F4BFD Q36178474-8B466E7A-4C20-4184-B6F2-1412AE728825 Q36526176-613E698B-9017-4155-A067-2CD62CA15005 Q36535217-65B5C19A-F0B2-480F-8E8B-32883D0E2CF0 Q36592191-5BAE04C5-C889-4B52-AEF2-08BBAC3C21CE Q36718213-54AB49C6-FBC2-402C-9ADE-5505F22B7A9A Q36739168-CE44B897-AB87-4D78-8999-E72C440CBA01 Q37050071-3453FA3A-7A8D-4653-898B-8AF7F2FED09E Q37069527-FA84E6E1-F6BB-4FA4-A2A9-D1D125516624 Q37086266-1815BD42-A09B-40C4-B5C5-B335AFB560D5 Q37135140-4714EB3D-2D05-4E39-B0F9-94F61D12C77C Q37148091-5543213C-8A7F-4014-BDFD-B3D8E14C5C48 Q37459083-15ED9541-B8A9-46C0-B474-D33E0ED75228 Q37498339-F8BE4587-FB4A-4EB8-BB16-F70971754E00 Q37781045-400B7245-159E-4653-9E97-8679617A0420 Q37810993-862F1B27-E2E4-4640-94F7-75217C7D2067

P2860

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

http://www.wikidata.org/entity/Q33601277

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@ast

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@en

type

label

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@ast

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@en

prefLabel

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@ast

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@en

P1433

Q33601277-EF445911-12C8-49BB-A5FF-ABADDD4B8D8B

P1476

Q33601277-7A4DA50E-F973-494C-97CD-A6BF1A68C128

P2093

Q33601277-140A4467-4064-46A3-82B5-38D5ABB836E9

Q33601277-15B582B6-580C-4B6C-BBA7-4461EB093295

Q33601277-2B35565F-5D5E-429C-A884-787D31987A88

Q33601277-5735F321-4BE8-4FD9-BE03-B8F24C4F419C

Q33601277-66C2C231-0972-4945-93E1-D823097F9203

Q33601277-87C238DA-CED4-4363-9D82-19D371DC9747

P2860

Q33601277-038E77FE-DE50-4066-BA12-B8D540677B8C

Q33601277-045B8DF4-A7F6-4301-8BBD-924847F1B174

Q33601277-1F415698-57EE-49D9-B97F-2B8ABAAC2734

Q33601277-26832484-88D2-42A2-AB85-7A3408CB0E4B

Q33601277-2F87564F-CAA0-4CBD-9FE2-6D17C4849656

Q33601277-3072EA32-4B04-4AC6-B4A2-F29F709C2736

Q33601277-3129FA92-4383-4F4C-8C07-A9187464B76C

Q33601277-32E23A99-A50C-4D7E-9D24-C2FAB264C866

Q33601277-3D471A3A-7801-4333-88C6-A4869C31FFE0

Q33601277-4057F710-D79D-41A5-A5C8-A8C3D64A0864

P304

Q33601277-1DA5E564-57E4-4738-8B8F-5A04DD4732E7

P31

Q33601277-F8F18BD2-1CD1-4B63-8842-132F3C4426E6

P356

Q33601277-A5691B87-9ACC-4BD3-AC68-0B60F10A20EE

P407

Q33601277-3CA1A7B7-C09C-4997-B119-C7E3F9D219C9

P433

Q33601277-27061991-3390-4A2C-B4E2-8FB9DD83B060

P478

Q33601277-986EBA8F-4639-45C8-89C6-32824385A431

P577

Q33601277-05A1EC1A-E737-49EE-B224-D18A5A509DBC

P698

Q33601277-40720589-F954-4D10-900F-5ACE6E0D65DF

P921

Q33601277-0F13DFE7-07BA-4C02-8E07-F31056705B49

Q33601277-16E5DCA7-690E-4FDC-80E5-64E462D7E197

Q33601277-86B00371-A82F-4375-A3C3-A0C26F471F2F

Q33601277-DD71EEAB-A1B9-4262-9F69-5E43501A3E21

P932

Q33601277-22EC344E-7A00-4945-BB28-F6C54AFF005B

P356

WNL.0B013E3181C7DA8E

P1433

P1476

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

@en

P2093

H P Flores

http://www.w3.org/2001/XMLSchema#string

J Hartlein

http://www.w3.org/2001/XMLSchema#string

J S Perlmutter

http://www.w3.org/2001/XMLSchema#string

L Taylor-Reinwald

http://www.w3.org/2001/XMLSchema#string

M A Burack

http://www.w3.org/2001/XMLSchema#string

N J Cairns

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Alpha-synuclein in Lewy bodies

Neuropathological stageing of Alzheimer-related changes

Staging of brain pathology related to sporadic Parkinson's disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

P304

77-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3181C7DA8E

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20038776

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

amyloid imaging

P932

2809026

http://www.w3.org/2001/XMLSchema#string